mTOR in tuberous sclerosis and other neurological disorders.

Suppr

超能文献

作者信息

Franz David Neal

出版信息

Epilepsia. 2007 Aug;48(8):1630-1; author reply 1632-4. doi: 10.1111/j.1528-1167.2007.01178_2.x.

DOI:10.1111/j.1528-1167.2007.01178_2.x

PMID:17692052

Abstract

摘要

相似文献

mTOR in tuberous sclerosis and other neurological disorders.

Epilepsia. 2007 Aug;48(8):1630-1; author reply 1632-4. doi: 10.1111/j.1528-1167.2007.01178_2.x.

Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.

Med Res Rev. 2006 Mar;26(2):160-80. doi: 10.1002/med.20049.

Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy.

Ann Neurol. 2008 Apr;63(4):415-7. doi: 10.1002/ana.21369.

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

Drug Discov Today. 2007 Feb;12(3-4):112-24. doi: 10.1016/j.drudis.2006.12.008. Epub 2006 Dec 15.

Biomedicine. A new view on--and hope for--an old disease.

Science. 2009 Jan 9;323(5911):203-5. doi: 10.1126/science.323.5911.203.

The pathophysiology of tuberous sclerosis complex.

Epilepsia. 2010 Feb;51 Suppl 1:27-9. doi: 10.1111/j.1528-1167.2009.02438.x.

Recent advances in neurobiology of Tuberous Sclerosis Complex.

Brain Dev. 2009 Feb;31(2):104-13. doi: 10.1016/j.braindev.2008.09.013. Epub 2008 Nov 22.

The genetic and familial aspects of neurological disease.

Practitioner. 1973 Sep;211(263):275-81.

Focal brain malformations: seizures, signaling, sequencing.

Epilepsia. 2009 Oct;50 Suppl 9:3-8. doi: 10.1111/j.1528-1167.2009.02289.x.

[3/3 Inhibitors of mTOR (sirolimus and everolimus)].

Soins. 2007 Sep(718):63-4.

引用本文的文献

The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.

Mol Neurobiol. 2012 Dec;46(3):662-81. doi: 10.1007/s12035-012-8314-5. Epub 2012 Jul 24.

Rapamycin for treatment of epilepsy: antiseizure, antiepileptogenic, both, or neither?

Epilepsy Curr. 2011 Mar;11(2):66-8. doi: 10.5698/1535-7511-11.2.66.

Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Neurosci Lett. 2011 Jun 27;497(3):231-9. doi: 10.1016/j.neulet.2011.02.037. Epub 2011 Feb 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

mTOR in tuberous sclerosis and other neurological disorders.

Epilepsia. 2007 Aug;48(8):1630-1; author reply 1632-4. doi: 10.1111/j.1528-1167.2007.01178_2.x.

Molecular activity of sirolimus and its possible application in tuberous sclerosis treatment.

Med Res Rev. 2006 Mar;26(2):160-80. doi: 10.1002/med.20049.

Rapamycin and tuberous sclerosis complex: from Easter Island to epilepsy.

Ann Neurol. 2008 Apr;63(4):415-7. doi: 10.1002/ana.21369.

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

Drug Discov Today. 2007 Feb;12(3-4):112-24. doi: 10.1016/j.drudis.2006.12.008. Epub 2006 Dec 15.

Biomedicine. A new view on--and hope for--an old disease.

Science. 2009 Jan 9;323(5911):203-5. doi: 10.1126/science.323.5911.203.

The pathophysiology of tuberous sclerosis complex.

Epilepsia. 2010 Feb;51 Suppl 1:27-9. doi: 10.1111/j.1528-1167.2009.02438.x.

Recent advances in neurobiology of Tuberous Sclerosis Complex.

Brain Dev. 2009 Feb;31(2):104-13. doi: 10.1016/j.braindev.2008.09.013. Epub 2008 Nov 22.

The genetic and familial aspects of neurological disease.

Practitioner. 1973 Sep;211(263):275-81.

Focal brain malformations: seizures, signaling, sequencing.

Epilepsia. 2009 Oct;50 Suppl 9:3-8. doi: 10.1111/j.1528-1167.2009.02289.x.

[3/3 Inhibitors of mTOR (sirolimus and everolimus)].

Soins. 2007 Sep(718):63-4.

引用本文的文献

The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.

Mol Neurobiol. 2012 Dec;46(3):662-81. doi: 10.1007/s12035-012-8314-5. Epub 2012 Jul 24.

Rapamycin for treatment of epilepsy: antiseizure, antiepileptogenic, both, or neither?

Epilepsy Curr. 2011 Mar;11(2):66-8. doi: 10.5698/1535-7511-11.2.66.

Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis.

Neurosci Lett. 2011 Jun 27;497(3):231-9. doi: 10.1016/j.neulet.2011.02.037. Epub 2011 Feb 24.